leisure time -WSS

leisure time

author：hotspot 2025-08-25 16:35:19 - browse：11891

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke Thursday at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

As Cytokinetics faces pressure to sell itself to a large pharma company following positive late-stage results of its heart drug, CEO Robert Blum maintains that the biotech can launch the treatment — what would be its first approved medication — on its own.

Cytokinetics reported top-line results of its drug, aficamten, in obstructive hypertrophic cardiomyopathy, or oHCM, last December, sending its shares up on speculation the company would get acquired. Full Phase 3 results released this week further suggest the drug could be used more flexibly than a similar treatment sold by Bristol Myers Squibb, but investors have questioned whether the biotech has the resources and salesforce to compete with a large pharma company.

Blum, speaking Thursday at a talk during STAT’s Breakthrough Summit West, said that if prospective buyers approach the company, he will talk to them, but “at the same time, we’re pushing forward, as we always have, with the original intention to build a commercial business. And that’s not something new. That’s not something that’s a result of a failed M&A dialogue.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： First transplant of an entire human eye performed

WSS

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Medical school prerequisites are outdated

Israel withdraws forces after 2

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Pentagon will tighten controls on classified information after Discord leak

leisure time

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Continuity nursing helped my family in our darkest PICU moments

Publishing genetic code of viruses could cause disaster

Affirmative action in medical school literally saved lives

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Peter Hotez and the public health issue of online harassment

What is STAT's opinion section for?

Medical leaders decry Supreme Court decision on affirmative action

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Trump demands the U.S. pay no more for drugs than other countries … again

A letter from the executive editor: STAT UnitedHealth investigation

entertainment

EU moves toward latest gene techniques in food production to counter climate change, shortages

Pope Francis asks Church to identify 21st

White House drug czar issues call for 'recovery

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Princess Kate attends Wimbledon with Roger Federer: See the photos

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

hotspot

Wikipedia

knowledge

hotspot